Bharat Immunologicals Financial Statements Trends

BIBCL -- India Stock  

INR 6.91  0.24  3.60%

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.

Bharat Immunologicals Shares Outstanding Analysis

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.
Shares Outstanding 
Public Shares 
More About Shares Outstanding | All Equity Analysis
Bharat Immunologicals Shares Outstanding  =
Bharat Immunologicals ValuationFundamentalsBuy or Sell

About Shares Outstanding

Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has 43.18M of shares currently outstending. This is 76.08% lower than that of the Healthcare sector, and 59.59% lower than that of Biotechnology industry, The Shares Outstanding for all stocks is 92.45% higher than the company.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in earnings per share category among related companies. It is rated below average in price to sales category among related companies .